Searchable abstracts of presentations at key conferences in endocrinology

ea0081oc8.4 | Oral Communications 8: Calcium and Bone | ECE2022

Is the “rebound phenomenon” following Denosumab discontinuation a risk factor for Zoledronic acid acute phase adverse reactions?

Zampogna Marta , Grassi Giorgia , Ghielmetti Alberto , Palmieri Serena , Arosio Maura , Vainicher Cristina Eller

Background: Zoledronic acid (ZOL) administration may cause acute phase adverse reactions (APR), which manifest with fever, malaise, bone and muscular pain, headache and/or gastrointestinal disturbances. Previous data suggest that high N-terminal propeptide of type 1 collagen (P1NP) and low 25, OH-vitaminD (VitD) levels are associated with higher incidence of APR, while the previous use of bisphosphonates is a protective factor. Lately, ZOL has been frequently used to mitigate ...

ea0081p558 | Calcium and Bone | ECE2022

Clinical and biochemical response to Burosumab treatment in two patients with X-linked hypophosfatemic rickets and tertiary hyperparathyroidism

Ghielmetti Alberto , Zampogna Marta , Palmieri Serena , Grassi Giorgia , Rosa Caruso Maria , Arosio Maura , Vainicher Cristina Eller

Introduction: in X-linked hypophosfatemic rickets (XLH) mutations of PHEX lead to elevated FGF-23 levels. Phosphate salts and calcitriol represented the only treatment option. Tertiary hyperparathyroidism (THPT) is a complication of XLH worsening the clinical features and constituting a contraindication to conventional treatment. Burosumab, a monoclonal antibody anti-FGF23, was recently approved in XLH. No data about Burosumab treatment in patients with XLH and THPT are availa...

ea0070aep134 | Bone and Calcium | ECE2020

Radiofrequency Echographic Multi Spectrometry (REMS) evaluation in patients with primary osteoporosis and primary hyperparathyroidism

Grassi Giorgia , Palmieri Serena , Cairoli Elisa , Chiodini Iacopo , Arosio Maura , Eller Vainicher Cristina

Background: Radiofrequency Echographic Multi Spectrometry (REMS) is a new ultrasound-based tool for bone mineral density (BMD) measurement, recently approved by FDA for the use in clinical routine to diagnose osteoporosis (OP) and to monitor bone changes. However, data on patients with secondary OP are not available. The aim of our study was to compare REMS and DXA ability in identifying clinical (cFX) and morphometric vertebral fractures (VFx) in patients with primary OP (pOP...

ea0073oc6.4 | Oral Communications 6: Calcium and Bone | ECE2021

Bisphosphonates after Denosumab withdrawal reduce the vertebral fractures incidence

Grassi Giorgia , Chiodini Iacopo , Palmieri Serena , Cairoli Elisa , Arosio Maura , Eller Vainicher Cristina

ObjectiveSeveral studies showed that patients discontinuing denosumab (Dmab) may experience bone loss and incident vertebral fractures (VFx) due to a rebound bone turnover increase, suggesting the need of anti-resorptive (i.e. bisphosphonate BPs) therapy to mitigate this occurrence. However, the morphometric VFx (morphoVFx) incidence after Dmab discontinuation is unknown and scarce data are available about the BPs effect on BMD changes and Fx risk in thi...

ea0099p220 | Adrenal and Cardiovascular Endocrinology | ECE2024

Adrenalectomy improves blood pressure and insulin secretion in adrenal incidentalomas and MACS

Morelli Valentina , Musolino Antonio , Palmieri Serena , Pugliese Flavia , Aresta Carmen , Frigerio Sofia , Arosio Maura , Corbetta Sabrina , Scillitani Alfredo , Chiodini Iacopo

Introduction: In patients with unilateral adrenal incidentaloma (AI) and mild autonomous cortisol secretion (MACS) the best therapeutic approach is still a matter of debate. The only available randomized study showed a short-term beneficial effect of surgery on diabetes and hypertension. Importantly, recent data demonstrated that MACS is associated to an increased risk of mortality, especially due to cardiovascular causes.Study aim: to evaluate, in the m...

ea0081p16 | Adrenal and Cardiovascular Endocrinology | ECE2022

Prevalence and clinical features of ARMC5 mutations in a single centre cohort of patients with bilateral adrenal incidentalomas

Frigerio Sofia , Morelli Valentina , Marta Elli Francesca , Vena Walter , Maffini Maria Antonia , Lucca Camilla , Piu Matteo , Mora Nicola , Palmieri Serena , Mantovani Giovanna , Arosio Maura

Introduction: Primary bilateral macronodular adrenal hyperplasia (PBMAH) is a rare cause of Cushing’s syndrome (CS). Some familial forms have been associated to gene ARMC5 (Armadillo repeat-containing protein 5) inactivating mutations. This study aimed to evaluate the prevalence and the complications of ARMC5 mutations in our cohort of patients with bilateral adrenal incidentalomas (BAI).Methods: 72 patients, referred to our Center...

ea0090p565 | Adrenal and Cardiovascular Endocrinology | ECE2023

The degree of cortisol secretion is associated with cardiometabolic complications in patients with nonfunctioning adrenal tumors

Favero Vittoria , Aresta Carmen , Parazzoli Chiara , Cairoli Elisa , Eller Vainicher Cristina , Palmieri Serena , Salcuni Antonio , Arosio Maura , Persani Luca , Scillitani Alfredo , Morelli Valentina , Chiodini Iacopo

Most adrenal incidentalomas are benign and can be divided into nonfunctioning adrenal tumors (NFAT) and tumors with mild autonomous cortisol secretion (MACS). Several studies suggest that MACS may result in an increased risk for mortality and cardiometabolic disease. The cardiometabolic risk in MACS is possibly related to the increased frequency of cardiovascular risk factors such as diabetes mellitus (DM) and hypertension (HT) induced by cortisol excess. This is confirmed by ...

ea0049ep1043 | Pituitary - Clinical | ECE2017

Salivary and serum cortisol levels by liquid chromatography tandem mass spectrometry after standard dose ACTH test in the diagnosis of central hypopituitarism

Morelli Valentina , Polledri Elisa , Mercadante Rosa , Sonzogni Beatrice , Mantovani Giovanna , Palmieri Serena , Malchiodi Elena , Verrua Elisa , Barbieri Anna Maria , Ferrante Emanuele , Arosio Maura , Fustinoni Silvia , Chiodini Iacopo

Objective: The diagnosis of central hypoadrenalism (HPAI) is a major clinical challenge. The gold standard procedure remains insuline tolerance test (ITT). Liquid chromatography tandem mass spectrometry (LC-MS/MS) is considered the best procedure for the evaluation of cortisol levels. This study aimed to evaluate cut-offs of serum (TM-SeC) and salivary cortisol (SaC) by LC-MS/MS and serum cortisol by ECLIA assay (E-SeC) after Standard dose ACTH test (SDCT) in diagnosing HPAI.<...

ea0099p226 | Adrenal and Cardiovascular Endocrinology | ECE2024

Sphingosine kinase 1 inhibitor safingol as a new possible therapeutic strategy for adrenocortical carcinoma

Nozza Emma , Catalano Rosa , Esposito Emanuela , Palmieri Serena , Altieri Barbara , Landwehr Laura-Sophie , Constanze Hantel , Sigala Sandra , Ferrante Emanuele , Mantovani Giovanna , Peverelli Erika

Sphingosine kinase 1 (SphK1) is the enzyme deputed to the phosphorylation of sphingosine in sphingosine-1-phosphate (S1P). S1P promotes ERK phosphorylation with increasing cellular proliferation, AKT phosphorylation, that induces apoptosis resistance and cell migration. It has been recently demonstrated that SphK1 is overexpressed in adrenocortical carcinoma (ACC) in comparison to adenomas (ACA) and that a high expression is related to worse outcome. Different SphK1 inhibitors...

ea0090oc9.2 | Oral Communications 9: Adrenal and Cardiovascular Endocrinology 2 | ECE2023

FLNA-binding partner Wee1 as a new potential pharmacological target in adrenocortical carcinomas

Esposito Emanuela , Catalano Rosa , Nozza Emma , Barbieri Anna Maria , Maioli Sara , Albrecht Ernst Geginat Jens , Marra Giusy , Treppiedi Donatella , Muro Genesio Di , Mangili Federica , Hantel Costanze , Palmieri Serena , Frigerio Sofia , Ferrante Emanuele , Arosio Maura , Mantovani Giovanna , Peverelli Erika

The cytoskeletal actin-binding protein filamin A (FLNA) is poorly expressed in adrenocortical carcinomas (ACC) compared to adenomas (ACA), and this might contribute to sustain the increased cell proliferation by downregulating IGF1R expression and its downstream signaling. In mouse neural progenitor cells, increased protein expression levels of the CDK1 kinase Wee1 have been found after loss of FLNA. This protein has a leading role in regulating the G2-M checkpoint and functio...